Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Vasudev Bhupathi"'
Autor:
Ying Jiang, Adam Simmons, Craig Hopkinson, David McDonnell, Vasudev Bhupathi, Bernard L. Silverman, Bei Yu, Jiani Yin, Christine Graham, Lauren DiPetrillo, René S. Kahn, Sergey Yagoda
Publikováno v:
Schizophrenia Research. 232:45-53
Aim A combination of olanzapine and samidorphan (OLZ/SAM) is in development for the treatment of patients with schizophrenia or bipolar I disorder and is intended to provide the efficacy of olanzapine while mitigating olanzapine-associated weight gai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6907f444d0129dbbe4fcbbf3da905356
https://doi.org/10.1016/j.schres.2021.04.009
https://doi.org/10.1016/j.schres.2021.04.009
Autor:
Brittany D. Roy, David McDonnell, Bei Yu, Christine Graham, Ying Jiang, Sergey Yagoda, Vasudev Bhupathi, Lauren DiPetrillo
Publikováno v:
CNS Spectrums. 27:233-233
BackgroundA combination of olanzapine and samidorphan (OLZ/SAM) that provides the efficacy of olanzapine while mitigating weight gain was recently approved by the FDA for the treatment of schizophrenia and bipolar I disorder. To improve communication
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cefc72621fe12b35ae1d064817bb1448
https://doi.org/10.1017/s1092852922000311
https://doi.org/10.1017/s1092852922000311
Autor:
Ying Jiang, Christine Graham, Vasudev Bhupathi, David McDonnell, René S. Kahn, Lauren DiPetrillo, Sergey Yagoda
Publikováno v:
Biological Psychiatry. 89:S241-S242
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30a4130cf56964e47d5d7143089c8fe8
https://doi.org/10.1016/j.biopsych.2021.02.605
https://doi.org/10.1016/j.biopsych.2021.02.605
Autor:
Davidd McDonnell, Ying Jiang, Bernard L. Silverman, Vasudev Bhupathi, Bei Yu, Craig Hopkinson, René S. Kahn, Lauren DiPetrillo, Adam Simmons, Jiani Yin, Christine Graham
Publikováno v:
CNS Spectrums. 26:155-156
ObjectiveCombination olanzapine and samidorphan (OLZ/SAM) is in development for treatment of schizophrenia and bipolar I disorder and is intended to provide the antipsychotic efficacy of olanzapine while mitigating olanzapine-associated weight gain.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0772b0476c36566d71184149973db61
https://doi.org/10.1017/s1092852920002485
https://doi.org/10.1017/s1092852920002485
Autor:
Bei Yu, David McDonnell, Lauren DiPetrillo, John W. Newcomer, Sergey Yagoda, Christine Graham, Vasudev Bhupathi, Ying Jiang
Publikováno v:
Biological Psychiatry. 89:S242
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee8e877e0cea93d737e0348addac6b2f
https://doi.org/10.1016/j.biopsych.2021.02.606
https://doi.org/10.1016/j.biopsych.2021.02.606
Autor:
Urdaneta, Veronica1 (AUTHOR) walter.straus@modernatx.com, Esposito, Daina B2 (AUTHOR), Dharia, Priyadarshani2 (AUTHOR), Moraga, Margot Stam1 (AUTHOR), Anteyi, Kate1 (AUTHOR), Oduyebo-Omotosho, Titi1 (AUTHOR), Rossi, Melissa1 (AUTHOR), Burton, Paul2,3 (AUTHOR), Vega, José M3 (AUTHOR), Dawson, Rachel2 (AUTHOR), Straus, Walter3 (AUTHOR) walter.straus@modernatx.com
Publikováno v:
Open Forum Infectious Diseases. Mar2024, Vol. 11 Issue 3, p1-10. 10p.
Autor:
Straus, Walter, Urdaneta, Veronica, Esposito, Daina B, Mansi, James A, Rodriguez, Cesar Sanz, Burton, Paul, Vega, José M
Publikováno v:
Clinical Infectious Diseases; 2/1/2023, Vol. 76 Issue 3, pe544-e552, 9p